AYTU BIOPHARMA, INC. — Key Metrics
2 years of history · ending 2025-06-30 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
52-Week Range
Trailing Returns
ROIC vs WACC
EPS (Diluted)
—
Book Value Per Share
—
Free Cash Flow Per Share
—
Cash Per Share
—
Revenue Per Share
—
OCF Per Share
—
Return on Equity
-58.1%
Return on Assets
-11.2%
Return on Invested Capital
-18.1%
Debt to Equity
0.57
Current Ratio
1.26
Quick Ratio
1.07
Asset Turnover
0.55
Days Sales Outstanding
171.31
Days Payables Outstanding
188.28
Days Inventory On Hand
203.08
Cash Conversion Cycle
186.10
R&D / Revenue
2.0%
SBC / Revenue
0.9%
Capex / Revenue
0.3%
Working Capital
$16M
Net Current Asset Value
$79M
Invested Capital
$30M
OCF / Net Income
0.14
FCF / Net Income
0.16
Accruals Ratio (Sloan)
-9.4%
Net Debt
$-20M
Net Debt / EBITDA
2.63
Interest Coverage
-2.11
Cash Coverage
-0.52
Capex Coverage
-8.50
Tangible Common Equity
$-23M
TCE / Total Assets
-18.7%
Goodwill / Total Assets
—
NOPAT
$-6M
Cash ROIC
-6.3%
WC / Revenue
24.3%
Capex / D&A
1.14
Reinvestment Rate
-0.4%
Asset Growth vs Revenue Growth
3.3%
Revenue 5Y CAGR
19.2%
Book Value 5Y CAGR
-27.6%
Stock Price (FY-end)
$2
Market Cap
—
P/S Ratio
—
P/B Ratio
—
Enterprise Value
—
EV / Sales
—
FCF Yield
—
Shareholder Yield
—
R&D Yield
—
Capex Yield
—
Shares Variation (YoY)
—
Beta (5Y)
0.83
Cost of Equity
8.6%
Cost of Debt (after tax)
26.9%
WACC
—
ROIC - WACC Spread
—
52W High
$3
52W Low
$1
Trailing Return 1Y
-24.3%
Trailing Return 5Y
-99.3%
F-Score (Piotroski)
4.00
Z-Score (Altman)
—
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.